HTA - Sahlgrenska Universitetssjukhuset
HTA - Sahlgrenska Universitetssjukhuset HTA - Sahlgrenska Universitetssjukhuset
Appendix 1:7b. 12-11-09 Mortality, early and late complications after shoulder arthroplasty in case series of total shoulder atrhroplasty (TSA) and hemiarthrioplasty (HA) Author, year Country Study design Number Follow-up Total mortality Complications Early complications Late Any complication of during follow-up directly related to (within 3 weeks complications shoulders /patients n= surgery after surgery) Aldinger, 2010 Chin, 2006 Churchill, 2005 Edwards, 2002 Farmer, 2007 Germany USA USA France USA Case series Case series Case series Case series Case series Age (years) 485 (6 different implants) 67 TSA: 431 65 TSA: 128 64 TSA: 478 HA: 77 67.6 TSA: 625 HA: 369 67.7 Mean 3.5 years (1-10 years) Mean 4.2 years 2.5 – 5 yrs Mean 3.6 yrs 0-6 years 2 % (n=11) Time of death not reported. Cause of death “unrelated to surgery” No data No Data 2 % (n=12) Time of death not reported. Cause of death “unrelated to surgery” 0 10 % (n=50) 12 % (n=53) 5 % (n= 6) 16 % (n=87) No Data No data 7 % (n=32) No Data 4 % (n=24) No Data No data 5 % (n=21) No Data 12 % (n=66) No Data 12 % (n=56) 12 % (n=53) 5 % (n= 6) 16 % (n=90) 8 % (n=75) Only in-hospital complications reported.
Appendix 1:7b. 12-11-09 Mortality, early and late complications after shoulder arthroplasty in case series of total shoulder atrhroplasty (TSA) and hemiarthrioplasty (HA) Author, year Country Study design Number Follow-up Total mortality Complications Early complications Late Any complication of during follow-up directly related to (within 3 weeks complications shoulders /patients n= surgery after surgery) Godenèche, 2002 Litchfield, 2011 Lynch, 1996 France Canada USA Case series Case series Case series Age (years) TSA: 251 HA: 17 TSA: 154 68.9 TSA: 368 62 Mean 2.5 yrs 2 yrs 2 years 0.4% (n=1) Only patients who survived 12 months after surgery included. Cause of death “unrelated to surgery” 2 % (n=3) 2 days postoperatively Cause of death pulmonary embolism (n=1) At 3 and 12 months. Causes of death “unrelated to surgery” (n=2) 0.3 % (n=1) Time of death not reported. Cause of death “unrelated to surgery” 9 % (n=23) 9 % (n=14) 5 % (n=17) Only neurological deficits/lesions reported. No Data 3 % (n=5) 4 % (n=15) Only neurological deficits/lesions reported No Data 6 % (n=9) 0.5 % (n=2) Only neurological deficits/lesions reported 9 % (n=23) 11 % (n=17) Including pulmonary embolism (n=1), stroke (n=1) and brain tumour (n=1)
- Page 1 and 2: Västra Götalandsregionen Sahlgren
- Page 3 and 4: Table of content Summary of the Hea
- Page 5 and 6: Complications Any kind of early com
- Page 7 and 8: Disease/disorder of Interest and Pr
- Page 9 and 10: Present Health Technology 3a Name/d
- Page 11 and 12: 3d PICO P= Patients, I= Interventio
- Page 13 and 14: Total shoulder arthroplasty versus
- Page 15 and 16: Ethical aspects 7 Ethical consequen
- Page 17 and 18: Unanswered Questions 10a Important
- Page 19 and 20: Side effects and complications: Ear
- Page 21 and 22: Komplikationer och biverkningar: Ti
- Page 23 and 24: Appendix 1 - 1 Comparison between t
- Page 25 and 26: Appendix 1 - 2 12-12-10/OS Comparis
- Page 27 and 28: Appendix 1 - 2 12-12-10/OS Comparis
- Page 29 and 30: Appendix 1 - 4 Comparison between t
- Page 31 and 32: Appendix 1 - 4 Comparison between t
- Page 33 and 34: Appendix 1 - 5 12-10-20 Comparison
- Page 35 and 36: Appendix 1 - 6 12-10-20 between tot
- Page 37 and 38: Appendix 1 - 6 12-10-20 between tot
- Page 39: Appendix 1:7a. 12-11-09 Mortality,
- Page 43 and 44: Appendix 1:7b. 12-11-09 Mortality,
- Page 45 and 46: Appendix 3, Search strategy, study
- Page 47 and 48: Search strategies Database: PubMed
- Page 49 and 50: Database: The Cochrane Library Date
- Page 51 and 52: Lo IK, Litchfield RB, Griffin S, Fa
- Page 53 and 54: Other references: AMSTAR [checklist
- Page 55 and 56: Number of studies Shoulder score -
- Page 57 and 58: Appendix 5. ETHICAL ANALYSIS OF IMP
- Page 59 and 60: Region Västra Götaland, HTA-centr
- Page 61: Sahlgrenska Universitetssjukhuset,
Appendix 1:7b. 12-11-09<br />
Mortality, early and late complications after shoulder arthroplasty in case series of total shoulder atrhroplasty (TSA) and hemiarthrioplasty (HA)<br />
Author, year Country Study design Number Follow-up Total mortality Complications Early complications Late<br />
Any complication<br />
of<br />
during follow-up directly related to (within 3 weeks complications<br />
shoulders<br />
/patients<br />
n=<br />
surgery<br />
after surgery)<br />
Godenèche, 2002<br />
Litchfield, 2011<br />
Lynch, 1996<br />
France<br />
Canada<br />
USA<br />
Case series<br />
Case series<br />
Case series<br />
Age<br />
(years)<br />
TSA: 251<br />
HA: 17<br />
TSA: 154<br />
68.9<br />
TSA: 368<br />
62<br />
Mean 2.5 yrs<br />
2 yrs<br />
2 years<br />
0.4% (n=1)<br />
Only patients who<br />
survived 12 months after<br />
surgery included.<br />
Cause of death<br />
“unrelated to surgery”<br />
2 % (n=3)<br />
2 days postoperatively<br />
Cause of death<br />
pulmonary embolism<br />
(n=1)<br />
At 3 and 12 months.<br />
Causes of death<br />
“unrelated to surgery”<br />
(n=2)<br />
0.3 % (n=1)<br />
Time of death not<br />
reported. Cause of death<br />
“unrelated to surgery”<br />
9 % (n=23)<br />
9 % (n=14)<br />
5 % (n=17)<br />
Only neurological<br />
deficits/lesions<br />
reported.<br />
No Data<br />
3 % (n=5)<br />
4 % (n=15)<br />
Only neurological<br />
deficits/lesions<br />
reported<br />
No Data<br />
6 % (n=9)<br />
0.5 % (n=2)<br />
Only neurological<br />
deficits/lesions<br />
reported<br />
9 % (n=23)<br />
11 % (n=17)<br />
Including pulmonary<br />
embolism (n=1),<br />
stroke (n=1) and brain<br />
tumour (n=1)
Change language